255 related articles for article (PubMed ID: 17876339)
1. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
Nam RK; Zhang WW; Loblaw DA; Klotz LH; Trachtenberg J; Jewett MA; Stanimirovic A; Davies TO; Toi A; Venkateswaran V; Sugar L; Siminovitch KA; Narod SA
Prostate Cancer Prostatic Dis; 2008; 11(3):241-6. PubMed ID: 17876339
[TBL] [Abstract][Full Text] [Related]
2. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
[TBL] [Abstract][Full Text] [Related]
3. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
[TBL] [Abstract][Full Text] [Related]
4. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci.
Witte JS; Suarez BK; Thiel B; Lin J; Yu A; Banerjee TK; Burmester JK; Casey G; Catalona WJ
Prostate; 2003 Dec; 57(4):298-308. PubMed ID: 14601026
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence.
Zhou X; Tan FK; Wang N; Xiong M; Maghidman S; Reveille JD; Milewicz DM; Chakraborty R; Arnett FC
Arthritis Rheum; 2003 Sep; 48(9):2585-92. PubMed ID: 13130478
[TBL] [Abstract][Full Text] [Related]
9. Investigation of reported associations between the 20q13 and 21q22 loci and pediatric-onset Crohn's disease in Canadian children.
Amre DK; Mack DR; Morgan K; Fujiwara M; Israel D; Deslandres C; Seidman EG; Lambrette P; Costea I; Krupoves A; Fegury H; Dong J; Grimard G; Levy E
Am J Gastroenterol; 2009 Nov; 104(11):2824-8. PubMed ID: 19623168
[TBL] [Abstract][Full Text] [Related]
10. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.
Gudmundsson J; Sulem P; Steinthorsdottir V; Bergthorsson JT; Thorleifsson G; Manolescu A; Rafnar T; Gudbjartsson D; Agnarsson BA; Baker A; Sigurdsson A; Benediktsdottir KR; Jakobsdottir M; Blondal T; Stacey SN; Helgason A; Gunnarsdottir S; Olafsdottir A; Kristinsson KT; Birgisdottir B; Ghosh S; Thorlacius S; Magnusdottir D; Stefansdottir G; Kristjansson K; Bagger Y; Wilensky RL; Reilly MP; Morris AD; Kimber CH; Adeyemo A; Chen Y; Zhou J; So WY; Tong PC; Ng MC; Hansen T; Andersen G; Borch-Johnsen K; Jorgensen T; Tres A; Fuertes F; Ruiz-Echarri M; Asin L; Saez B; van Boven E; Klaver S; Swinkels DW; Aben KK; Graif T; Cashy J; Suarez BK; van Vierssen Trip O; Frigge ML; Ober C; Hofker MH; Wijmenga C; Christiansen C; Rader DJ; Palmer CN; Rotimi C; Chan JC; Pedersen O; Sigurdsson G; Benediktsson R; Jonsson E; Einarsson GV; Mayordomo JI; Catalona WJ; Kiemeney LA; Barkardottir RB; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
Nat Genet; 2007 Aug; 39(8):977-83. PubMed ID: 17603485
[TBL] [Abstract][Full Text] [Related]
11. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
Cunningham JM; McDonnell SK; Marks A; Hebbring S; Anderson SA; Peterson BJ; Slager S; French A; Blute ML; Schaid DJ; Thibodeau SN;
Prostate; 2003 Dec; 57(4):335-46. PubMed ID: 14601030
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk.
Tindall EA; Severi G; Hoang HN; Ma CS; Fernandez P; Southey MC; English DR; Hopper JL; Heyns CF; Tangye SG; Giles GG; Hayes VM;
Carcinogenesis; 2010 Oct; 31(10):1748-54. PubMed ID: 20403914
[TBL] [Abstract][Full Text] [Related]
13. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility.
Chang BL; Zheng SL; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Carpten JD; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2002 Mar; 62(6):1784-9. PubMed ID: 11912155
[TBL] [Abstract][Full Text] [Related]
14. Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
Meyer A; Schürmann P; Ghahremani M; Kocak E; Brinkhaus MJ; Bremer M; Karstens JH; Hagemann J; Machtens S; Dörk T
Urol Oncol; 2009; 27(4):373-6. PubMed ID: 18625567
[TBL] [Abstract][Full Text] [Related]
15. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.
Wang L; McDonnell SK; Slusser JP; Hebbring SJ; Cunningham JM; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
Cancer Res; 2007 Apr; 67(7):2944-50. PubMed ID: 17409399
[TBL] [Abstract][Full Text] [Related]
16. Y chromosome haplotypes and prostate cancer in Sweden.
Lindström S; Adami HO; Adolfsson J; Wiklund F
Clin Cancer Res; 2008 Oct; 14(20):6712-6. PubMed ID: 18927315
[TBL] [Abstract][Full Text] [Related]
17. Associations between G/A1229, A/G3944, T/C30875, C/T48200 and C/T65013 genotypes and haplotypes in the vitamin D receptor gene, ultraviolet radiation and susceptibility to prostate cancer.
Moon S; Holley S; Bodiwala D; Luscombe CJ; French ME; Liu S; Saxby MF; Jones PW; Fryer AA; Strange RC
Ann Hum Genet; 2006 Mar; 70(Pt 2):226-36. PubMed ID: 16626332
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Turner AR; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Prostate; 2003 Jun; 56(1):37-44. PubMed ID: 12746845
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
Hofer MD; Kuefer R; Maier C; Herkommer K; Perner S; Demichelis F; Paiss T; Vogel W; Rubin MA; Hoegel J
Cancer Res; 2009 Jan; 69(2):640-6. PubMed ID: 19147579
[TBL] [Abstract][Full Text] [Related]
20. Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT.
Larson GP; Ding Y; Cheng LS; Lundberg C; Gagalang V; Rivas G; Geller L; Weitzel J; MacDonald D; Archambeau J; Slater J; Neuberg D; Daly MB; Angel I; Benson AB; Smith K; Kirkwood JM; O'Dwyer PJ; Raskay B; Sutphen R; Drew R; Stewart JA; Werndli J; Johnson D; Ruckdeschel JC; Elston RC; Krontiris TG
Cancer Res; 2005 Feb; 65(3):805-14. PubMed ID: 15705877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
